Cancer immunotherapy marks a paradigm shift in cancer treatment, leveraging the body's immune system to combat cancer cells. Unlike conventional treatments, such as chemotherapy, immunotherapy empowers the immune system to recognize and eliminate cancerous cells. Techniques like immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines are tailored to target specific cancer types, offering patients a potentially less toxic and more effective alternative. Nevertheless, hurdles persist, including tumor resistance and immune-related adverse effects. Continued research endeavors strive to refine existing strategies and introduce novel approaches, underscoring a promising trajectory in the ongoing battle against cancer.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States